{"id":320,"date":"2026-05-26T19:15:34","date_gmt":"2026-05-26T19:15:34","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-news\/?p=320"},"modified":"2026-05-26T19:15:34","modified_gmt":"2026-05-26T19:15:34","slug":"drugs-who-needs-to-regsiter","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-news\/2026\/05\/26\/drugs-who-needs-to-regsiter\/","title":{"rendered":"DRUGS \u2013 WHO NEEDS TO REGSITER"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">As per FD&amp;C act, all domestic and foreign establishments\nthat manufacture, prepare, propagate, compound, or process drug products for\ncommercial distribution in the United States must register regardless the\nestablishment manufacture human drugs, animal drugs, active pharmaceutical manufacturers,\nor biologics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Who Must Register<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As per FDA establishment registration guidelines, business\noperations below are required to register with FDA.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Drug  Manufacturers:<\/strong> Facilities producing active pharmaceutical ingredients (APIs), bulk drugs, or finished dosage forms.<\/li><li><strong>Contract Manufacturers:<\/strong> Third-party organizations that manufacture or process  products on behalf of another company.<\/li><li><strong>Re-packers and Re-labelers:<\/strong> Companies that take bulk drug products, split them into smaller commercial packages, or alter the product labeling.<\/li><li><strong>Drug Salvagers:<\/strong> Entities that retrieve, recondition, or analyze drugs      affected by disasters (e.g., fires or floods) to determine if they are fit      for commercial sale. <\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Foreign facilities exporting drug products to the U.S.\nmarket must register their establishments <strong>before<\/strong> shipping their goods.\nThey are legally required to appoint a single <a href=\"https:\/\/www.fdahelp.us\/fda_registration\/us-fda-agents-requirements.html\"><strong>U.S.\nAgent<\/strong><\/a> who lives or operates a business physically within the United\nStates. This agent serves as the official point of communication between the\nFDA and the foreign firm.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The FDA exempts certain entities from registration if they manage\ndrugs in the ordinary course of their local business operations.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Pharmacies, hospitals, clinics, and licensed practitioners<\/strong> dispensing or      administering drugs directly to patients.<\/li><li><strong>Research facilities<\/strong> utilizing drug products solely for teaching, analysis, or      scientific research without commercial sale.<\/li><li><strong>Private label distributors (PLDs)<\/strong> who market drugs under their own brand name      but utilize a registered third-party facility to oversee the actual      manufacturing, repacking, or relabeling.<\/li><li><strong>Storage and transport facilities<\/strong> that only hold or move drug products without      altering the product or its packaging. <\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">All registered establishment must submit the list of drugs\nmanufactured in their facility with a unique <a href=\"https:\/\/www.fdahelp.us\/fda-labeler-code.html\">National Drug code (NDC).<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Initial drug listings must be submitted within 3 days after\nregistration of the establishment via Structured Product Labeling (SPL) format.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.fdahelp.us\/fda-drug-registration.html\">Establishment\nregistration<\/a> must be renewed annually between October 1 and December 31.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">Liberty Management Group Ltd<\/a>, provides assistance with <a href=\"https:\/\/www.fdahelp.us\/fda-drug-registration.html\">drugs establishment registration<\/a><a href=\"https:\/\/www.fdahelp.us\/ndc-labeler-code.html\">, NDC labeler code request<\/a>, <a href=\"https:\/\/www.fdahelp.us\/api-listing.html\">Drug listings<\/a> and <a href=\"https:\/\/www.fdahelp.us\/fda_registration\/us-fda-agents-requirements.html\">US agent service to foreign facilities<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sudha S<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory Consultant<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Email : office@libertymanagement.us<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As per FD&amp;C act, all domestic and foreign establishments that manufacture, prepare, propagate, compound, or process drug products for commercial distribution in the United States must register regardless the establishment manufacture human drugs, animal drugs, active pharmaceutical manufacturers, or biologics. Who Must Register As per FDA establishment registration guidelines, business operations below are required to &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-news\/2026\/05\/26\/drugs-who-needs-to-regsiter\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;DRUGS \u2013 WHO NEEDS TO REGSITER&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[42,40],"class_list":["post-320","post","type-post","status-publish","format-standard","hentry","category-fda-registration-drug","tag-fda-drug-registration","tag-fda-drug-registration-renewal"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/comments?post=320"}],"version-history":[{"count":2,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/320\/revisions"}],"predecessor-version":[{"id":322,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/posts\/320\/revisions\/322"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/media?parent=320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/categories?post=320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-news\/wp-json\/wp\/v2\/tags?post=320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}